Second Line Capital LLC raised its holdings in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 20.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 638,640 shares of the biopharmaceutical c